IMS trades up after allocation

A Eu550m term loan from US pharmaceutical industry intelligence provider IMS Health traded up in the secondary market after being allocated to lenders on Wednesday, said market participants.

  • 18 Feb 2010

The euro tranche, priced alongside a $1.25bn dollar loan, was priced at a margin of 375bp with a 1.75% Euribor floor and issued at 99%. It had reached 100.325% on Thursday, said one fund manager, who welcomed the deal.

The deal backs the buyout of IMS by TPG Capital ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 4,755 19 11.75
2 Citi 4,288 14 10.60
3 Rabobank 2,633 4 6.51
4 Goldman Sachs 2,615 4 6.46
5 Barclays 2,603 8 6.43

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 57,945.74 181 12.35%
2 Citi 57,243.86 174 12.20%
3 Wells Fargo Securities 48,214.86 152 10.28%
4 JPMorgan 33,301.70 114 7.10%
5 Credit Suisse 25,010.27 80 5.33%